Conferences

Hybrid (In-person & Online)

We are excited to invite researchers, academicians, industry professionals, and students to participate in the AHTBE 25, which will be held at the Annacis Research and Event Centre, Vancouver, BC, Canada, on 30–31 August 2025. This forum aims to bring together experts to discuss the latest innovations, challenges, and future directions in healthcare technology and biomedical engineering.

Conference Chair

Dr. Ghazanfar Latif
President, Canadian Association for Artificial Intelligence and Future Studies (AAIFS) &
Assistant Professor, Computing Science Department, Thompson Rivers University, Kamloops, BC, Canada

Topics of Interest:

• Track 1: Biomedical Imaging and Signal Processing
• Track 2: Artificial Intelligence and Machine Learning in Healthcare
• Track 3: Healthcare Robotics and Automation
• Track 4: Wearable and Implantable Devices
• Track 5: Telemedicine and e-Health
• Track 6: Biomedical Materials and Tissue Engineering
• Track 7: Healthcare Data Analytics and Management
• Track 8: AI Assistive Technologies

Important Dates

Full Paper/Abstract Submission Deadline: 10 August 2025

Abstract Acceptance Notification: 18 August 2025

Registration Deadline: 25 August 2025

Guide for Authors

To submit your full paper/abstract, please click the following link:  https://cmt3.research.microsoft.com/AHTBE2025

To register for the event, please click the following link:
https://ahtbe.ca/registration/

For more details regarding the submission of abstracts, posters, and slides and publication opportunities, please refer to the “Instructions for Authors” section of the following website: https://ahtbe.ca/paper-submission/.

For any inquiries regarding this event, please contact: glatif@tru.ca 

We look forward to seeing you at the International Conference on Advancement in Healthcare Technology and Biomedical Engineering (AHTBE 25).

https://ahtbe.ca/

The European and Spanish Congress of Emergency Radiology begins with a global call for participation, bringing together scientific societies, radiologists, emergency specialists, and healthcare professionals from across Europe. The organizing committee works closely with academic and clinical institutions to design a high-level scientific program, focusing on the latest diagnostic advances, clinical protocols, and emerging technologies in emergency medical imaging.

https://congresoeser-serau.com/

We are thrilled to invite you to the XXVII World Congress of Neurology (WCN 2025), taking place in the vibrant city of Seoul, Republic of Korea, from October 12 to 15, 2025. Co-hosted by the Korean Neurological Association, this global event will bring together neurologists, researchers, and healthcare professionals to explore the latest advancements in the field.

WCN 2025 promises a dynamic program featuring groundbreaking research, insightful keynote speakers, and engaging scientific sessions covering a wide range of topics, from neurogenetics to dementia research and stroke management. Attendees can also take part in interactive teaching courses, thought-provoking poster presentations, and the exciting Tournament of the Minds.

Key Dates:

• Abstract Submission Deadline: 2 April
• Early Bird Registration Deadline: 23 July 

Beyond the academic program, WCN 2025 offers valuable networking opportunities and a chance to experience the unique blend of tradition and technology in Seoul, a city known for its leadership in medical innovation.

We look forward to welcoming you to Seoul in 2025!

https://wcn-neurology.com/#

The "Clinical and Research Insights in Infectious Diseases" event gathers leading experts to present cutting-edge advancements in the diagnostics, management, and therapeutic strategies of infectious diseases. The agenda addresses both state-of-the-art knowledge and emerging research, providing a comprehensive view of current challenges and future directions.

The program is structured in two days of work, during which practical clinical applications will be discussed, such as antimicrobial stewardship, innovations in microbiological diagnostics, and the role of PK/PD in therapy optimization. Presentations will cover the immunological patterns in septic patients, the role of next-generation sequencing in clinical practice, and the impact of pH on antibiotic performance. Moreover, it will also explore infections by Staphylococcus aureus, including its intracellular role in bone infections, interactions with platelets, and virulence factors. The session on Penicillin-Binding Proteins (PBPs) and fosfomycin will highlight key research opportunities and potential synergistic effects.

The topics covered include Gram-positive and Gram-negative infections, with talks on Cutibacterium acnes, Corynebacterium (non-diphtheriae), listeriosis in pregnancy, and enterococcal infections, focusing on antimicrobial therapy. Special attention is given to non-fermenting Gram-negative, multidrug-resistant pathogens, and emerging treatment options, including novel antibiotics and subcutaneous antibiotic therapy. Fungal infections in diverse patient populations will be explored, including the ICU, transplantation, and HIV contexts.

By fostering collaboration between clinicians and researchers, this event aims to bridge gaps between bench and bedside, promote novel therapeutic strategies, and address the evolving landscape of infectious diseases.

More information is available on Congress’ website:

https://insightsinid.net/

Chairs: Bob Löwenberg, Hartmut Döhner, Benjamin Ebert

Venue: Estoril Congress Center
Av. Amaral,
2765-192 Estoril, Portugal

Start date: October 16, 2025
End date: October 18, 2025

Link: https://www.esh.org/conference/7th-international-conference-acute-myeloid-leukemia-molecular-and-translational-advances-in-biology-and-treatment/

About the conference:
The successful biannual ESH Conferences on acute myeloid leukemia (AML) have established themselves as scientific and educational programs at the interface of molecular and biological developments and clinical translation. Novel technological, molecular, and immunologic approaches are rapidly creating novel insights into the biology and therapeutic perspectives of AML.
The cutting-edge program of the conference will deal with the molecular and functional features of leukemic stem cells and their interaction with the microenvironment, the role of somatic and germ-line mutations and epigenetic alterations in the biology of AML, the genomics of leukemogenesis, advances in molecular diagnostics and developmental therapeutics with a focus on molecular and immunotherapeutic targeted therapeutics. Special attention will be given to the utility and promise of novel therapeutic agents.

Words from the Conference Chairs:
“We wish to invite and encourage you to join us at the ESH AML meeting upcoming in 2025. These conferences have an outstanding record of talks from international leaders in the basic science and clinical treatment of leukemia, along with robust discussions and many opportunities for interactions.
The seventh bi-annual conference in this series will offer discussions on the latest developments and emerging insights in the fascinating biology and rapidly changing clinical landscape of AML. For the attendees, it holds the promise of another inspiring interactive experience.”
–Hartmut Döhner, Benjamin Ebert and Bob Löwenberg

Continuing Medical Education (CME) credit points will be awarded to physicians for the time they spend at the meeting improving their knowledge and skills. ESH is a provider of the European Hematology CME system.

Conference Main Scientific Topics:

• Predisposition and Aging;
• Clonal Hematopoiesis;
• Targeting Clonal Hematopoiesis;
• Therapeutic Targeting 1;
• Metabolic and Proteomic Alterations;
• Cellular Therapy;
• Therapeutic Targeting 2;
• Measurable Residual Disease in AML;
• Therapeutic Targeting 3;
• Therapeutic Targeting 4.

This meeting will be valuable to those seeking the following:

- A cutting-edge scientific program—from basic science to clinical and therapeutic applications and perspectives;
- Multiple opportunities for scientific interaction with an international faculty of distinguished experts;
- An emphasis on critical discussion.
The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and with insight into controversies in the field.

The meeting will be of interest to:
- PhD students, postdocs, junior and senior biologists, and practicing clinicians (MD, PhD, MD-PhD), hematologists, and oncologists in training;
- Residents and biologists in training.

The program will include the following:
- Plenary Sessions;
- Panel Discussions;
- Simultaneous Meet the Expert Sessions;
- Mentored Poster Walks;
- Ample time for in-depth discussion.

https://www.esh.org/conference/7th-international-conference-acute-myeloid-leukemia-molecular-and-translational-advances-in-biology-and-treatment/

Network with over 1500 colleagues at Europe’s largest protein and antibody engineering event—hailed by attendees as "the best biologics technology meeting in Europe." The 2025 agenda will feature expanded content on ML/AI applications in protein engineering, multispecific antibodies, ADCs, emerging targets, oncology, expression, and analytical characterisation. 

https://www.pegsummiteurope.com/

Bringing together key scientific leaders representing renowned academic and healthcare organizations, as well as pharmaceutical and biotech companies, to discuss the latest scientific and technological advancements through a 2-day programme. 

Our combined agenda, which includes our NGS & Clinical Diagnostics and Multi-Omics in Single Cell and Spatial Analysis programmes, offers a one-stop-shop platform for multi-omics approaches via cutting-edge presentations and C-level interactive sessions, bridging the gap between fundamental omics research and real-life applications in drug development and diagnostics. Do not miss out on experiencing leading-edge science to stay ahead of upcoming breakthroughs predicted to impact the next-generation multi-omics market.

https://oxfordglobal.com/precision-medicine/events/nextgen-multi-omics-2025

Welcome from Chairs

Dear Colleagues,

We are delighted to invite you to the 33rd World Congress on Controversies in Obstetrics, Gynecology, and Infertility (COGI), taking place at the Ergife Palace Hotel in Rome, Italy, from November 27–29, 2025.

This year’s congress, under the leadership of the COGI Congress Chairpersons and our esteemed local chairperson, will once again bring together world-renowned experts in OBGYN and infertility. The program is designed to address the most pressing and controversial issues in the field through debates, discussions, and practical, clinically oriented solutions. Ample time will also be provided for meaningful interaction between speakers and attendees, fostering dynamic and thought-provoking conversations.

As always, we are committed to offering an inspiring and scientifically robust program that equips busy clinicians with practical insights and actionable solutions for daily practice.

We also encourage you to contribute to the congress by submitting your research for consideration in the form of oral presentations, e-Posters, and moderated e-Posters.

For our young colleagues, born after 1990, we invite you to submit your work for the Young Scientist Award, which celebrates and recognizes emerging talent in the field.

COGI 2025 promises to be an invigorating and rewarding experience, offering not only cutting-edge science but also an opportunity to connect with peers from around the world in the historic and vibrant city of Rome.

We look forward to welcoming you to COGI 2025 for what promises to be another outstanding congress dedicated to advancing our knowledge in the field of OBGYN and infertility.

Warm regards,
The COGI Congress Chairpersons 

https://cogi-congress.org/2025-rome-italy/

The 18th Annual World Cancer Congress (WCC) will take place in Athens, Greece, from April 15 to 17, 2026. This event offers a unique platform on which to explore the latest advancements in cancer research, innovative therapies, and clinical drug trials. Participants will have opportunities to share their work through oral presentations and poster sessions while engaging with leading international experts. The congress aims to facilitate meaningful discussions that bridge scientific discoveries with clinical applications, providing valuable prospects for professional development and collaboration. Set in the historic city where Hippocrates established medical ethics, the event combines cutting-edge cancer research with the inspiring legacy of Greek medical heritage.

Registration website: https://www.bitcongress.com/cancer2026/registernow.asp.

Best wishes,

https://www.bitcongress.com/cancer2026/default.asp